Because peptides are large molecules, they require injection to enter the bloodstream intact
Some GLP-1 receptor agonists, like Tirzepatide, have been shown to reduce the risk of major cardiovascular events (e.g., heart attack, stroke) in people with Type 2 diabetes and existing heart disease
Details of the work were published in 2014
Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, et al
Patients with dexterity challenges, such as arthritis, neuropathy, or other fine motor skills, may find it hard to apply and remove the patch themselves, requiring extra support
The term describes facial hollowing, looser skin, deeper folds, and a more aged appearance that can become noticeable after substantial weight loss on semaglutide, tirzepatide, or another GLP-1 medication